S. Simpson-Yap Et Al. , "Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis," NEUROLOGY , vol.97, no.19, 2021
Simpson-Yap, S. Et Al. 2021. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis. NEUROLOGY , vol.97, no.19 .
Simpson-Yap, S., De Brouwer, E., Kalincik, T., Rijke, N., Hillert, J. A., Walton, C., ... Edan, G.(2021). Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis. NEUROLOGY , vol.97, no.19.
Simpson-Yap, Steve Et Al. "Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis," NEUROLOGY , vol.97, no.19, 2021
Simpson-Yap, Steve Et Al. "Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis." NEUROLOGY , vol.97, no.19, 2021
Simpson-Yap, S. Et Al. (2021) . "Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis." NEUROLOGY , vol.97, no.19.
@article{article, author={Steve Simpson-Yap Et Al. }, title={Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis}, journal={NEUROLOGY}, year=2021}